These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 16362283

  • 1. Glucagon secretion in relation to insulin sensitivity in healthy subjects.
    Ahrén B.
    Diabetologia; 2006 Jan; 49(1):117-22. PubMed ID: 16362283
    [Abstract] [Full Text] [Related]

  • 2. Glucose intolerance is predicted by low insulin secretion and high glucagon secretion: outcome of a prospective study in postmenopausal Caucasian women.
    Larsson H, Ahrén B.
    Diabetologia; 2000 Feb; 43(2):194-202. PubMed ID: 10753041
    [Abstract] [Full Text] [Related]

  • 3. Glucose modulation of insulin and glucagon secretion is altered in impaired glucose tolerance.
    Larsson H, Berglund G, Ahrén B.
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1778-82. PubMed ID: 7775622
    [Abstract] [Full Text] [Related]

  • 4. Insulin resistant subjects lack islet adaptation to short-term dexamethasone-induced reduction in insulin sensitivity.
    Larsson H, Ahrén B.
    Diabetologia; 1999 Aug; 42(8):936-43. PubMed ID: 10491753
    [Abstract] [Full Text] [Related]

  • 5. Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance.
    Larsson H, Ahrén B.
    Diabetes Care; 2000 May; 23(5):650-7. PubMed ID: 10834425
    [Abstract] [Full Text] [Related]

  • 6. Failure to adequately adapt reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance.
    Larsson H, Ahrén B.
    Diabetologia; 1996 Sep; 39(9):1099-107. PubMed ID: 8877295
    [Abstract] [Full Text] [Related]

  • 7. Glucose-dependent arginine stimulation test for characterization of islet function: studies on reproducibility and priming effect of arginine.
    Larsson H, Ahrén B.
    Diabetologia; 1998 Jul; 41(7):772-7. PubMed ID: 9686917
    [Abstract] [Full Text] [Related]

  • 8. Insulin secretion and insulin sensitivity in relation to fasting glucose in healthy subjects.
    Ahrén B.
    Diabetes Care; 2007 Mar; 30(3):644-8. PubMed ID: 17327334
    [Abstract] [Full Text] [Related]

  • 9. Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitus.
    Ahrén B, Larsson H, Holst JJ.
    J Clin Endocrinol Metab; 1997 Feb; 82(2):473-8. PubMed ID: 9024239
    [Abstract] [Full Text] [Related]

  • 10. Insulin secretory capacity and the regulation of glucagon secretion in diabetic and non-diabetic alcoholic cirrhotic patients.
    Kruszynska YT, Goulas S, Wollen N, McIntyre N.
    J Hepatol; 1998 Feb; 28(2):280-91. PubMed ID: 9514541
    [Abstract] [Full Text] [Related]

  • 11. Diminished insulin and glucagon secretory responses to arginine in nondiabetic subjects with a mutation in the hepatocyte nuclear factor-4alpha/MODY1 gene.
    Herman WH, Fajans SS, Smith MJ, Polonsky KS, Bell GI, Halter JB.
    Diabetes; 1997 Nov; 46(11):1749-54. PubMed ID: 9356021
    [Abstract] [Full Text] [Related]

  • 12. Leptin--a regulator of islet function?: its plasma levels correlate with glucagon and insulin secretion in healthy women.
    Ahrén B, Larsson H.
    Metabolism; 1997 Dec; 46(12):1477-81. PubMed ID: 9439547
    [Abstract] [Full Text] [Related]

  • 13. Capacity to secrete islet hormones after subtotal pancreatectomy for pancreatic cancer.
    Ahrén B, Andrén-Sandberg A.
    Eur J Surg; 1993 Apr; 159(4):223-7. PubMed ID: 8102543
    [Abstract] [Full Text] [Related]

  • 14. Islet dysfunction in obese women with impaired glucose tolerance.
    Larsson H, Ahrén B.
    Metabolism; 1996 Apr; 45(4):502-9. PubMed ID: 8609839
    [Abstract] [Full Text] [Related]

  • 15. Impaired glucose tolerance (IGT) is associated with reduced insulin-induced suppression of glucagon concentrations.
    Ahrén B, Larsson H.
    Diabetologia; 2001 Nov; 44(11):1998-2003. PubMed ID: 11719830
    [Abstract] [Full Text] [Related]

  • 16. Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicity.
    Solomon TP, Knudsen SH, Karstoft K, Winding K, Holst JJ, Pedersen BK.
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4682-91. PubMed ID: 23043193
    [Abstract] [Full Text] [Related]

  • 17. Abnormal glucagon response to arginine and its normalization in obese hyperinsulinaemic patients with glucose intolerance: importance of insulin action on pancreatic alpha cells.
    Hamaguchi T, Fukushima H, Uehara M, Wada S, Shirotani T, Kishikawa H, Ichinose K, Yamaguchi K, Shichiri M.
    Diabetologia; 1991 Nov; 34(11):801-6. PubMed ID: 1769438
    [Abstract] [Full Text] [Related]

  • 18. Plasma leptin levels correlate to islet function independently of body fat in postmenopausal women.
    Larsson H, Elmståhl S, Ahrén B.
    Diabetes; 1996 Nov; 45(11):1580-4. PubMed ID: 8866564
    [Abstract] [Full Text] [Related]

  • 19. Glucose potentiation of arginine-induced insulin secretion is impaired in subjects with a glucokinase Glu256Lys mutation.
    Wajngot A, Alvarsson M, Glaser A, Efendic S, Luthman H, Grill V.
    Diabetes; 1994 Dec; 43(12):1402-6. PubMed ID: 7958490
    [Abstract] [Full Text] [Related]

  • 20. Modulation of arginine-induced glucagon release by epinephrine and glucose levels in man.
    Beard JC, Weinberg C, Pfeifer MA, Best JD, Halter JB, Porte D.
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1271-7. PubMed ID: 6841561
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.